Joint Purification Systems was recently cleared through its second round of clinical trials, with over 90% of participating patients in the study continuing to show positive results after one year of treatment. JPS will begin its third phase of clinical trials, with the device implanted, in May.
Meduloc has rounded up phase II of product development. We are currently raising funds to support FDA testing and 510k process as well as phase II of product development.
Throughout the calendar year, Cor Medical Ventures makes its way to exhibitions and trade shows to meet new partners and investors in person while showcasing our innovations. This year come say hi and introduce yourself:
March 2020: AAOS (booth ##)
April 2020: something